The Emory Medicine Magazine hosted a virtual Dinner with a Doctor with Long COVID experts and panelists impacted by Long COVID. All were asked to share their knowledge and respective experiences.
RECOVER Atlanta Hub Principal Investigator, Igho Ofotokun, MD, MSc, and RECOVER Atlanta Emory at Grady Site Principal Investigator, Tiffany Walker, MD, represented as Long COVID experts, sharing developing knowledge.
RECOVER Atlanta Principal Investigator, Dr. Igho Ofotokun, MD, MSc, attended IDWeek 2023 and shared an update in RECOVER's Long COVID research. Dr. Ofotokun gave insight into the RECOVER participant population, key findings, and additional areas of research actively being conducted nationwide.
The national consortium of RECOVER Investigators share the study's protocol, giving insight into the study's purpose, design, and goals. RECOVER, with its Adult cohort, intends to rapidly improve understanding of, and ability to predict, treat, and prevent post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID.
The NIH RECOVER Study (all adult sites across the United States) shares a first look into what they have learned about Long COVID from participants. Based on the data from almost 10,000 adults, researchers find trends in symptoms of persons who are experiencing Long COVID which can include postexertional malaise (symptoms getting worse after minor physical or mental efforts), fatigue (constantly feeling of being tired and/or weak), dizziness, brain fog and gastrointestinal symptoms.
Researchers explore the relationship between diabetes and Long COVID, concluding that persons with diabetes are at high risk for experiencing Long COVID. Also, research suggests that a diabetes diagnosis can be a symptom of Long COVID in some persons.
